GetTopicDetailResponse(id=27289466c8, topicName=IFNγ, introduction=IFNγ, content=null, image=null, comments=3, allHits=1074, url=https://h5.medsci.cn/topic?id=9466, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=88288, tagList=[TagDto(tagId=88288, tagName=IFNγ)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1690750, encodeId=95d91690e507e, content=<a href='/topic/show?id=27289466c8' target=_blank style='color:#2F92EE;'>#IFNγ#</a>, objectTitle=Lancet Oncol：腫瘤突變負荷聯(lián)合IFNγ基因表達特征可預(yù)測靶向治療的III期黑色素瘤患者的預(yù)后, objectType=article, longId=187354, objectId=313c18e3543f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=313c18e3543f, replyNumber=0, likeNumber=110, createdTime=2020-07-06, rootId=0, userName=fangcong, userId=b5f629121759, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=313c18e3543f, moduleTitle=Lancet Oncol：腫瘤突變負荷聯(lián)合IFNγ基因表達特征可預(yù)測靶向治療的III期黑色素瘤患者的預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=313c18e3543f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1690749, encodeId=35951690e4903, content=<a href='/topic/show?id=27289466c8' target=_blank style='color:#2F92EE;'>#IFNγ#</a>, objectTitle=Blood：艾曲波帕（eltrombopag）可在IFNγ介導(dǎo)的炎性環(huán)境中維持人造血干/祖細胞的存活和功能, objectType=article, longId=163408, objectId=1a0e163408e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a0e163408e3, replyNumber=0, likeNumber=78, createdTime=2019-06-19, rootId=0, userName=fangcong, userId=b5f629121759, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a0e163408e3, moduleTitle=Blood：艾曲波帕（eltrombopag）可在IFNγ介導(dǎo)的炎性環(huán)境中維持人造血干/祖細胞的存活和功能, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1a0e163408e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1690748, encodeId=65201690e485c, content=<a href='/topic/show?id=27289466c8' target=_blank style='color:#2F92EE;'>#IFNγ#</a>, objectTitle=CLIN CANCER RES：IFNγ+T細胞增加與低劑量地西他濱抗腫瘤治療臨床反應(yīng)有關(guān), objectType=article, longId=117965, objectId=458811e96533, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=458811e96533, replyNumber=0, likeNumber=76, createdTime=2018-01-07, rootId=0, userName=fangcong, userId=b5f629121759, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=458811e96533, moduleTitle=CLIN CANCER RES：IFNγ+T細胞增加與低劑量地西他濱抗腫瘤治療臨床反應(yīng)有關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=458811e96533)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
